Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Use of amlezanox in inhibiting epithelial-mesenchymal transition and anti-tumor metastasis

An anti-tumor metastases and aminolezanol technology, applied in the field of ammonialezano for inhibiting epithelial-mesenchymal transition and anti-tumor metastasis, can solve the problems of severe infection, low immunity, metabolic disorders, etc., and achieve inhibition of epithelial-mesenchymal transition. and tumor metastasis, the effect of huge socioeconomic benefits

Active Publication Date: 2020-07-03
LEADINGEN BIOTECH INC
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The low immunity of tumor patients leads to secondary severe infection and even death; 2. Nutritional depletion and metabolic disorders

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Use of amlezanox in inhibiting epithelial-mesenchymal transition and anti-tumor metastasis
  • Use of amlezanox in inhibiting epithelial-mesenchymal transition and anti-tumor metastasis
  • Use of amlezanox in inhibiting epithelial-mesenchymal transition and anti-tumor metastasis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0035] Experimental materials and equipment: PC3 cell line ( CRL-1435 TM ), (Cat no114-07), double chemiluminescent reporter system (pLenti-EcadPm-mCherry-PA-Spacer-VimPm-eGFP-PA-hPKG-Puro), small molecule compound library (Taosu)

[0036] Experimental steps:

[0037] 1. Transfect the double chemiluminescence system and verify the working efficiency

[0038] 1.1 Inoculate the single cell suspension of the human prostate cancer cell line PC3 evenly into a six-well plate, and when the cells grow to a density of about 80%, use (Cat no114-07) transfection reagent will double fluorescent reporter system pLenti-EcadPm-mCherry-PA-Spacer-VimPm-eGFP-PA-hPKG-Puro( figure 1 ) into PC3 cells, the specific transfection method refers to Transfection Reagent Instructions.

[0039] 1.2 After 72 hours of transfection, observe the cell state under a microscope. When the cell state is good, add 1ug / ml puromycin to the medium for cell selection.

[0040] 1.3 After 48 hours of puromycin...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention provides application of amlexanox to inhibition of epithelial-mesenchymal transition (EMT) and anti-tumor metastasis. The effective concentration of the amlexanox for inhibition of epithelial-mesenchymal transition and anti-tumor metastasis is 100 nM to 10 muM. Whether various micromolecular compounds are EMT target points or not is screened by an efficient and dynamic screening method, the obtained amlexanox can effectively inhibit epithelial-mesenchymal transition and tumor metastasis, a new method is provided for treatment target points for treating tumor metastasis clinically, and great social and economic benefits can be brought.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to the use of amlezanox in inhibiting epithelial-mesenchymal transition and anti-tumor metastasis. Background technique [0002] With the rapid development of the global economy, science and humanities, human beings are paying more and more attention to the topic of global health. According to the 2015 CBD 【1】 Statistical analysis of the global burden of disease shows that ischemic heart disease, cerebrovascular disease and other diseases threaten human health, among which lung cancer, liver cancer, colon cancer, breast cancer and other cancers also top the list, becoming one of the number one killers of human beings . From the clear definition of cancer to the present, whether government agencies, researchers or civil organizations have invested decades in order to uncover the mystery of cancer and overcome cancer, but until recently, with economic development, population increa...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/436A61P35/04
CPCA61K31/436
Inventor 高维强朱鹤程姹萍吉忠忠
Owner LEADINGEN BIOTECH INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com